ACTRN12617000235303招募中1 期
A Phase 1b Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GS-9688 in Patients with Chronic Hepatitis B
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
A Study of Tarlatamab in Participants With Neuroendocrine Prostate Cancer (DeLLpro-300)JPRN-jRCT2031210415Tagashira Shuzo60
撤回
不适用
A Phase 1b Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of Oprozomib in Combination With Pomalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple MyelomaKahler's diseaseplasma cell myelomaRelapsed or Refractory Multiple Myeloma10018865NL-OMON46679Amgen3
进行中（未招募）
1 期
A Study of Bemarituzumab Monotherapy and Combination With Other Anti-cancer Therapy in SqNSCLC WithFGFR2b Overexpression (FORTITUDE-201)Squamous-Cell Non-Small-Cell Lung CancerJPRN-jRCT2051220022Kaneda Hirokazu180
已完成
不适用
A Phase 1b Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of Delta-like Protein 3 Half-life Extended Bispecific T-cell Engager AMG 757 in Subjects with De Novo or Treatment Emergent Neuroendocrine Prostate Cancerneuro-endocriene prostaatkankerNeuroendocrine Prostate Cancer10036958Prostate CancerNL-OMON51934Amgen3
进行中（未招募）
1 期
A safety and efficacy study of the drug BGB-290 in combination with Temozolomide (TMZ) in patients with ovarian, breast, prostate, lung and stomach cancer.ocally Advanced or Metastatic Solid Tumors (ovarian cancer, triple negative breast cancer (TNBC), metastatic castration-resistant prostate cancer (mCRPC), small cell lung cancer (SCLC), and gastric cancer)EUCTR2017-001553-14-GBBeiGene USA, Inc.250